Analytical Data
-
基因名
IGLV2-14
- Application
-
别名
IGLV2-14Immunoglobulin lambda variable 2-14; Ig lambda chain V-II region NIG-84; Ig lambda chain V-II region TOG; Ig lambda chain V-II region VIL
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P01704
-
表达区间
1-230aa
-
氨基酸序列
MSVLPGPLSQAVLTQPSSLSASPGASASLTCTLRRGFYVYDYRIYWYQQKSGRSPQYLLRHRSDSDKQQGSGVPSRFSGSKDASANAGILVISGLRSEDEADYYCMVWHNSAWVFGGGTRLTVLSQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS
-
分子量
51.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human HNRNPK Protein，His
Cat：PA1000-1476
Recombinant Human ZSCAN1 Protein，His
Cat：PA2000-4296
Protein Description
The IGLV2-14 gene, part of the immunoglobulin light chain variable gene family, is crucial for the adaptive immune response, specifically in the production of antibodies. Research on IGLV2-14 recombinant proteins has gained significance due to their potential applications in therapeutic antibody development and diagnostics. As an essential component of immunoglobulin synthesis, variations and mutations in the IGLV genes can influence antibody diversity and specificity. Understanding the structure and function of IGLV2-14 may facilitate the design of monoclonal antibodies with enhanced binding affinities for antigens, including pathogens and tumors. Furthermore, recombinant IGLV2-14 proteins can serve as valuable tools in elucidating antibody responses in various diseases and for vaccine development. Advances in molecular cloning and protein expression technologies have enabled the production of IGLV2-14 proteins in various systems, allowing for detailed characterization and functional studies. This research is pivotal not only in the field of immunology but also in developing strategies to combat infectious diseases and cancer, highlighting the relevance of IGLV2-14 in current biomedical research and its potential to contribute to personalized medicine.
